ReGear Life Sciences has added additional funding to support its deep tissue heating pain management device, according to a recent regulatory filing. The therapeutic heating company has raised $850,000 in equity since July, according to the new document. That’s up from the $500,000 in equity the company revealed in a filing last August. Pittsburgh-based ReGear […]
Pain management medical device company ReGear Life Sciences has raised $500,000 to boost its sales and marketing efforts. The Pittsburgh-based company’s portable, 4-pound, pain management device, called the ReBound, works by generating heat deep within a patient’s body tissue. It’s targeted at the sports and long-term care industries. The fundraise comes from the company’s lead […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
After starting in college athletics, therapeutic heating company ReGear Life Sciences is turning to long-term care facilities to fuel its "dramatic" growth. The Pittsburgh-based company's portable, 4-pound, pain management device, called the ReBound, works by generating heat deep within a patient's body tissue.
ReGear Life Sciences will use its $2.5 million Series A investment to build a version of its pain-management product, ReBound, for the home health-care market. It also plans to expand further into sports medicine, physical medicine, rehabilitation and the chiropractic markets.